(2018). A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia.
Chicago Style (17th ed.) CitationA Phase II Study to Evaluate the Safety and Efficacy of Topical 3% Amphotericin B Cream (Anfoleish) for the Treatment of Uncomplicated Cutaneous Leishmaniasis in Colombia. 2018.
MLA (8th ed.) CitationA Phase II Study to Evaluate the Safety and Efficacy of Topical 3% Amphotericin B Cream (Anfoleish) for the Treatment of Uncomplicated Cutaneous Leishmaniasis in Colombia. 2018.
Warning: These citations may not always be 100% accurate.